Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation: a retrospective study from a single institution
Objective The outcomes of patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are poor.However, the risk factors for relapse in this context remain unclear.Methods We Bondage retrospectively assessed 84 consecutive adult AML patients who underwent allo-HSCT and achieved complet